71 related articles for article (PubMed ID: 2994487)
1. Role of myosin phosphorylation in contractility of a platelet aggregate.
Bromberg ME; Sevy RW; Daniel JL; Salganicoff L
Am J Physiol; 1985 Sep; 249(3 Pt 1):C297-303. PubMed ID: 2994487
[TBL] [Abstract][Full Text] [Related]
2. The platelet strip. I. A low-fibrin contractile model of thrombin-activated platelets.
Salganicoff L; Loughnane MH; Sevy RW; Russo M
Am J Physiol; 1985 Sep; 249(3 Pt 1):C279-87. PubMed ID: 3898863
[TBL] [Abstract][Full Text] [Related]
3. Role of phosphorylation in mediating the association of myosin with the cytoskeletal structures of human platelets.
Fox JE; Phillips DR
J Biol Chem; 1982 Apr; 257(8):4120-6. PubMed ID: 7040379
[TBL] [Abstract][Full Text] [Related]
4. The platelet strip. II. Pharmacomechanical coupling in thrombin-activated human platelets.
Salganicoff L; Sevy RW
Am J Physiol; 1985 Sep; 249(3 Pt 1):C288-96. PubMed ID: 2994486
[TBL] [Abstract][Full Text] [Related]
5. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
Salzman EW
Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP.
Oda A; Druker BJ; Smith M; Salzman EW
Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
Steen VM; Holmsen H
Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
[TBL] [Abstract][Full Text] [Related]
8. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of platelet strips.
Yamakado T; Nishikawa M; Azuma H; Hidaka H
Eur J Pharmacol; 1983 Aug; 91(4):441-7. PubMed ID: 6684577
[TBL] [Abstract][Full Text] [Related]
10. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
11. Effect of forskolin on platelet deaggregation and cyclic AMP generation.
Kariya T; Morito F; Sakai T; Takahata K; Yamanaka M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):119-21. PubMed ID: 2999615
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate).
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Feb; 75(2):257-9. PubMed ID: 6892270
[TBL] [Abstract][Full Text] [Related]
13. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
Zahavi M; Zahavi J; Kakkar VV
Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
15. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
Macfarlane DE; Mills DC; Srivastava PC
Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
[No Abstract] [Full Text] [Related]
16. Effect of epinephrine on rapid ADP-induced aggregation, protein phosphorylation, and cytoplasmic calcium dynamics of platelets: a quenched-flow study.
Carty DJ; Jones GD; Freas DL; Gear AR
J Lab Clin Med; 1988 Nov; 112(5):603-11. PubMed ID: 3183492
[TBL] [Abstract][Full Text] [Related]
17. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
[No Abstract] [Full Text] [Related]
18. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
Lam SC; Guccione MA; Packham MA; Mustard JF
Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
[TBL] [Abstract][Full Text] [Related]
19. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
Haslam RJ; Rosson GM
Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
[No Abstract] [Full Text] [Related]
20. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
Antonikov IM; Alekseev OV; Chernukh AM
Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
